Gene · 7074
Papers2,121
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,121
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HuR (ELAVL1) Stabilizes SOX9 mRNA and Promotes Migration and Invasion in Breast Cancer Cells. | Cancers (Basel) | 2024 | 38254873 | PubTator, text mining | PubMed |
| Deficiency in SPOP-mediated ubiquitination and degradation of TIAM1 promotes gastric cancer progression. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38246227 | PubTator, text mining | PubMed |
| Photoactivatable Nanobody Conjugate Dimerizer Temporally Resolves Tiam1-Rac1 Signaling Axis. | Adv Sci (Weinh) | 2024 | 38225743 | PubTator, text mining | PubMed |
| Studying early structural changes in SOS1 mediated KRAS activation mechanism. | Curr Res Struct Biol | 2024 | 38188543 | PubTator, text mining | PubMed |
| Cell polarity changes in cancer initiation and progression. | J Cell Biol | 2024 | 38091012 | PubTator, text mining | PubMed |
| Metastasis and cancer associated fibroblasts: taking it up a NOTCH. | Front Cell Dev Biol | 2023 | 38269089 | PubTator, text mining | PubMed |
| Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants. | Proc Natl Acad Sci U S A | 2023 | 38134199 | PubTator, text mining | PubMed |
| Glucocorticoid receptor regulates the epithelial-mesenchymal transition process through GR/ZEB1/E-cad and is involved in breast cancer endocrine drug resistance-a bioinformatics analysis. | Transl Cancer Res | 2023 | 38130302 | PubTator, text mining | PubMed |
| p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells. | Cell Death Dis | 2023 | 38123597 | PubTator, text mining | PubMed |
| Tiam1 methylation by NSD2 promotes Rac1 signaling activation and colon cancer metastasis. | Proc Natl Acad Sci U S A | 2023 | 38113258 | PubTator, text mining | PubMed |
| Exploring the interaction between extracellular matrix components in a 3D organoid disease model to replicate the pathophysiology of breast cancer. | J Exp Clin Cancer Res | 2023 | 38102637 | PubTator, text mining | PubMed |
| Thy-1 (CD90)-regulated cell adhesion and migration of mesenchymal cells: insights into adhesomes, mechanical forces, and signaling pathways. | Front Cell Dev Biol | 2023 | 38099295 | PubTator, text mining | PubMed |
| The Rac-GEF Tiam1 controls integrin-dependent neutrophil responses. | Front Immunol | 2023 | 38077328 | PubTator, text mining | PubMed |
| Nectin-4 regulates cellular senescence-associated enlargement of cell size. | Sci Rep | 2023 | 38062106 | PubTator, text mining | PubMed |
| Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches. | Front Immunol | 2023 | 38022534 | PubTator, text mining | PubMed |
| miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 stability. | Cancer Cell Int | 2023 | 38017477 | PubTator, text mining | PubMed |
| Effects of S-Adenosylhomocysteine Hydrolase Downregulation on Wnt Signaling Pathway in SW480 Cells. | Int J Mol Sci | 2023 | 38003292 | PubTator, text mining | PubMed |
| CRISPR/Cas9: a powerful tool in colorectal cancer research. | J Exp Clin Cancer Res | 2023 | 37993945 | PubTator, text mining | PubMed |
| The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis. | J Ovarian Res | 2023 | 37986114 | PubTator, text mining | PubMed |
| Single-cell and bulk RNA sequencing reveals Anoikis related genes to guide prognosis and immunotherapy in osteosarcoma. | Sci Rep | 2023 | 37980450 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7074/papers?page=4